---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-030195"
form_type: "8-K"
ticker: "DFTX"
cik: "0001813814"
company_name: "Definium Therapeutics, Inc."
filed_at: "2023-06-27T23:59:59+00:00"
generated_at: "2026-06-13T16:28:17.907236+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# MindMed annual meeting elects six board nominees; FCM MM Holdings challenges preliminary vote results

## Summary
- Six company-nominated directors elected: Barrow, Bruhn, Crystal, Gryska, Krebs, Vallone.
- FCM MM Holdings nominees Freeman, Farzaneh, Jain, Wodka failed to be elected; FCM challenging results.
- KPMG LLP re-appointed as auditor with 14.86M votes for, 0.39M against, 1.08M abstain.
- Company states it does not expect FCM challenge to affect outcome or quorum.

## SEC filing metadata
- accession: 0000950170-23-030195
- form_type: 8-K
- ticker: DFTX
- cik: 0001813814
- company_name: Definium Therapeutics, Inc.
- filed_at: 2023-06-27T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1813814/000095017023030195/0000950170-23-030195-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1813814/000095017023030195/mnmd-20230621.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-030195
- JSON: https://secwatch.observer/filing/0000950170-23-030195.json
- Plain text: https://secwatch.observer/filing/0000950170-23-030195.txt

## Key facts
- Shareholder Votes
  Definium Therapeutics, Inc. shareholders approved Appointment of KPMG LLP as auditor of the Company until the close of the 2024 Annual Meeting at the 2023-06-21 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-06-21
  source text: The shareholders approved the appointment of KPMG LLP as the auditor of the Company until the close of the 2024 Annual Meeting, by the following votes: Votes For Votes Against Votes Abstain 14,857,596 394,019 1,078,880
  evidence_url: https://www.sec.gov/Archives/edgar/data/1813814/000095017023030195/0000950170-23-030195-index.htm
- Shareholder Votes
  Definium Therapeutics, Inc. shareholders approved Election of Directors: Company Board Nominees and FCM MM Holdings, LLC Nominees at the 2023-06-21 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-06-21
  source text: The Company's six nominees, Robert Barrow, Dr. Suzanne Bruhn, Dr. Roger Crystal, David Gryska, Andreas Krebs, and Carol A. Vallone, were each elected to serve as a member of the Company's Board of Directors (the "Board") until the 2024 annual general meeting of shareholders (the "2024 Annual Meeting") and until his or her successor is duly elected or qualified, by the following votes: Company Board Nominee Votes For Votes Withheld Robert Barrow 8,154,619 6,260,614 Dr. Suzanne Bruhn 10,708,185 3,707,052 Dr. Roger Crystal 8,208,815 6,206,151 David Gryska 12,248,893 2,166,343 Andreas Krebs 8,099,276 6,315,960 Carol A. Vallone 8,125,466 6,289,772 FCM MM Holdings, LLC Nominee Votes For Votes Withheld Dr. Scott Freeman 6,023,932 7,779,083 Dr. Farzin Farzaneh 6,022,144 7,780,172 Vivek Jain 5,950,387 7,852,629 Alexander J. Wodka 5,921,398 7,881,619
  evidence_url: https://www.sec.gov/Archives/edgar/data/1813814/000095017023030195/0000950170-23-030195-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.